Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback